shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    NCI Outstanding Investigator Award (R35 Clinical Trial Optional)

    RFA-CA-22-045

    National Institutes of Health

    Opening date 26 Jul 2022, 12:00AM

    Closing date 7 Nov 2024, 12:00AM

    Funding Opportunity Number: RFA-CA-22-045

    Opportunity Category: Discretionary

    CFDA Number(s): 93.393 -- Cancer Cause and Prevention Research,93.394 -- Cancer Detection and Diagnosis Research,93.395 -- Cancer Treatment Research,93.396 -- Cancer Biology Research,93.397 -- Cancer Centers Support Grants,93.398 -- Cancer Research Manpower,93.399 -- Cancer Control

    Cost Sharing or Matching Requirement: No

    Posted Date: Jul 26, 2022 12:00:00 AM EDT

    Closing Date: Nov 07, 2024 12:00:00 AM EST

    Award Ceiling: $600000

    Award Floor: none

    Eligible Applicants: Private institutions of higher education,City or township governments,Small businesses,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,County governments,Public housing authorities/Indian housing authorities,Public and State controlled institutions of higher education,For profit organizations other than small businesses,Native American tribal organizations (other than Federally recognized tribal governments),Others (see text field entitled "Additional Information on Eligibility" for clarification),State governments,Special district governments,Independent school districts,Native American tribal governments (Federally recognized)

    Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

    Agency Name: National Institutes of Health

    Description: This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

    Grantor Contact Information: NIH OER Webmaster OERWebmaster03@od.nih.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept